世界の感染症用体外診断(IVD)市場2020-2027:製品別(機器、試薬、サービス)、技術別、用途別、エンドユーザー別、地域別

◆英語タイトル:Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Size study, by Product (Instruments, Reagent, Services), by Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), by Application (Streptococcus, Clostridium Difficile, Carbapenem-resistant enterobacterial testing (CRE), Respiratory virus, Tuberculosis (TB) & drug-resistant TB, Human Immunodeficiency Virus (HIV), Gonorrhea, Chlamydia, Others), by End-Use (Point of Care, Central Laboratories, Others) and Regional Forecasts 2020-2027
◆商品コード:BZW21AP140
◆発行会社(リサーチ会社):Bizwit Research&Consulting
◆発行日:2021年3月25日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、GCC諸国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research&Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research&Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本書では、世界の感染症用体外診断(IVD)市場を調査対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、製品別(機器、試薬、サービス)分析、技術別(イムノアッセイ、分子診断、微生物、その他)分析、用途別(連鎖球菌、クロストリジウム・ディフィシル、カルバペネム耐性腸内細菌検査(CRE)、呼吸器ウイルス、結核(TB)・薬剤耐性結核(TB))分析、エンドユーザー別(ポイントオブケア(POC)、中央研究所、その他)分析、地域別分析、競争状況、調査プロセスなどを整理しました。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界の感染症用体外診断(IVD)市場規模:製品別(機器、試薬、サービス)
・世界の感染症用体外診断(IVD)市場規模:技術別(イムノアッセイ、分子診断、微生物、その他)
・世界の感染症用体外診断(IVD)市場規模:用途別(連鎖球菌、クロストリジウム・ディフィシル、カルバペネム耐性腸内細菌検査(CRE)、呼吸器ウイルス、結核(TB)・薬剤耐性結核(TB))
・世界の感染症用体外診断(IVD)市場規模:エンドユーザー別(ポイントオブケア(POC)、中央研究所、その他)
・世界の感染症用体外診断(IVD)市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Infectious Diseases in-Vitro Diagnostics (IVD) Market is valued at approximately USD 54 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.8% over the forecast period 2020-2027. Infectious Diseases in-Vitro Diagnostics (IVD) is a type of medical devices, which needs the use of reagents and assays to treat a medical condition. The information shown through these diagnostic tools helps physicians in productive management of medical settings in each stage. In addition, the use and handling of in-vitro diagnostics needs significant technical expertise, and therefore, instruments are utilized in specific medical facilities to perform a diagnosis of diseases. For example, infectious diseases IVD products are frequently using in many healthcare facilities, such as point-of care centers, standalone laboratories, and hospitals. Moreover, there have been significant developments have been advanced in these products that have enabled a paradigm shift from point of care testing to laboratory testing, which is assisting in expansion of infectious diseases IVD market. Furthermore, the rise in prevalence of infectious diseases in the developed and developing region, along with the increasing government support and consumer awareness in regards of faster diagnostics are the few factors responsible for the high CAGR of the market during the forecast period.

For instance, according to the Avert organization, in 2018, nearly 37.9 million individuals were affected by HIV (including 1.7 million children), with a global prevalence rate of HIV is estimated nearly 0.8% among adults. Similarly, the U.S. Department of Health & Human Services has valued about 21.7 million people living with HIV in 2017, signifying a surge of 2.3 million from 2016. Likewise, as per the survey of Center for Disease Control and Prevention, the symptomatic illness of influenza in the US is nearly 30,000,000 during 2016-17 and is increased to approximately 49,000,000 in 2017-18. This, in turn, is likely to strengthen the demand for Infectious Diseases in-Vitro Diagnostics (IVD) products, globally. However, the high prices of IVD testing is one of the major factors limiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global Infectious Diseases in-Vitro Diagnostics (IVD) market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising demand for the Point-of-care and molecular diagnostic devices, along with the rise in presence of market vendors in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as growing prevalence of infectious diseases along with growing healthcare infrastructure in developing countries, such as China and India, are the few factors creating lucrative growth opportunities for the Infectious Diseases in-Vitro Diagnostics (IVD) market in the region.

Major market player included in this report are:
Becton, Dickinson and Company
BioMérieux SA
Abbott Laboratories
Quidel Corporation
OraSure Technologies, Inc.
Hologic Inc. (Gen Probe)
Qiagen
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Bio-Rad Laboratories, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Instruments
Reagent
Services

By Technology:
Immunoassay
Molecular Diagnostics
Microbiology
Others

By Application:
Streptococcus
Clostridium Difficile
Carbapenem-resistant enterobacterial testing (CRE)
Respiratory virus
Tuberculosis (TB) & drug-resistant TB
Human Immunodeficiency Virus (HIV)
Gonorrhea
Chlamydia
Others

By End-Use:
Point of Care
Central Laboratories
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Infectious Diseases in-Vitro Diagnostics (IVD) Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Region, 2018-2027 (USD Billion)
1.2.2. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Product, 2018-2027 (USD Billion)
1.2.3. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Technology, 2018-2027 (USD Billion)
1.2.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Application, 2018-2027 (USD Billion)
1.2.5. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by End-Use, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Dynamics
3.1. Infectious Diseases in-Vitro Diagnostics (IVD) Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Product
5.1. Market Snapshot
5.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Product, Performance – Potential Analysis
5.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
5.4.1. Instruments
5.4.2. Reagent
5.4.3. Services
Chapter 6. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Technology
6.1. Market Snapshot
6.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Technology, Performance – Potential Analysis
6.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
6.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
6.4.1. Immunoassay
6.4.2. Molecular Diagnostics
6.4.3. Microbiology
6.4.4. Others
Chapter 7. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Application
7.1. Market Snapshot
7.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Application, Performance – Potential Analysis
7.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
7.4.1. Streptococcus
7.4.2. Clostridium Difficile
7.4.3. Carbapenem-resistant enterobacterial testing (CRE)
7.4.4. Respiratory virus
7.4.5. Tuberculosis (TB) & drug-resistant TB
7.4.6. Human Immunodeficiency Virus (HIV)
7.4.7. Gonorrhea
7.4.8. Chlamydia
7.4.9. Others
Chapter 8. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by End-Use
8.1. Market Snapshot
8.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by End-Use – Potential Analysis
8.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)
8.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
8.4.1. Point of Care
8.4.2. Central Laboratories
8.4.3. Others
Chapter 9. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, Regional Analysis
9.1. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Regional Market Snapshot
9.2. North America Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.2.1. U.S. Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.2.1.1. Product breakdown estimates & forecasts, 2017-2027
9.2.1.2. Technology breakdown estimates & forecasts, 2017-2027
9.2.1.3. Application breakdown estimates & forecasts, 2017-2027
9.2.1.4. End-Use breakdown estimates & forecasts, 2017-2027
9.2.2. Canada Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3. Europe Infectious Diseases in-Vitro Diagnostics (IVD) Market Snapshot
9.3.1. U.K. Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3.2. Germany Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3.3. France Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3.4. Spain Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3.5. Italy Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3.6. Rest of Europe Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4. Asia-Pacific Infectious Diseases in-Vitro Diagnostics (IVD) Market Snapshot
9.4.1. China Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4.2. India Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4.3. Japan Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4.4. Australia Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4.5. South Korea Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4.6. Rest of Asia Pacific Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.5. Latin America Infectious Diseases in-Vitro Diagnostics (IVD) Market Snapshot
9.5.1. Brazil Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.5.2. Mexico Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.6. Rest of The World Infectious Diseases in-Vitro Diagnostics (IVD) Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Becton, Dickinson and Company
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. BioMérieux SA
10.2.3. Abbott Laboratories
10.2.4. Quidel Corporation
10.2.5. OraSure Technologies, Inc.
10.2.6. Hologic Inc. (Gen Probe)
10.2.7. Qiagen
10.2.8. F. Hoffmann-La Roche Ltd.
10.2.9. Siemens Healthcare GmbH
10.2.10. Bio-Rad Laboratories, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. Global Infectious Diseases in-Vitro Diagnostics (IVD) market, report scope
TABLE 2. Global Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by Product 2017-2027 (USD Billion)
TABLE 4. Global Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by Technology 2017-2027 (USD Billion)
TABLE 5. Global Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 6. Global Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by End-Use 2017-2027 (USD Billion)
TABLE 7. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 23. U.S. Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 24. U.S. Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 25. U.S. Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Canada Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 27. Canada Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 28. Canada Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. UK Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 30. UK Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 31. UK Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. Germany Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 33. Germany Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 34. Germany Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. France Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 36. France Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 37. France Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Spain Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 39. Spain Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 40. Spain Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. Italy Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 42. Italy Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 43. Italy Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. ROE Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 45. ROE Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 46. ROE Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. China Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 48. China Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 49. China Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. India Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 51. India Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 52. India Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Japan Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 54. Japan Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 55. Japan Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. Australia Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 57. Australia Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 58. Australia Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 59. South Korea Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 60. South Korea Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 61. South Korea Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 62. ROPAC Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 63. ROPAC Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 64. ROPAC Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 65. Brazil Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 66. Brazil Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 67. Brazil Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 68. Mexico Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 69. Mexico Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 70. Mexico Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 71. ROLA Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 72. ROLA Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 73. ROLA Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 74. ROW Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 75. ROW Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 76. ROW Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 77. List of secondary sources, used in the study of global Infectious Diseases in-Vitro Diagnostics (IVD) market
TABLE 78. List of primary sources, used in the study of global Infectious Diseases in-Vitro Diagnostics (IVD) market
TABLE 79. Years considered for the study
TABLE 80. Exchange rates considered

List of figures
FIG 1. Global Infectious Diseases in-Vitro Diagnostics (IVD) market, research methodology
FIG 2. Global Infectious Diseases in-Vitro Diagnostics (IVD) market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Infectious Diseases in-Vitro Diagnostics (IVD) market, key trends 2019
FIG 5. Global Infectious Diseases in-Vitro Diagnostics (IVD) market, growth prospects 2020-2027
FIG 6. Global Infectious Diseases in-Vitro Diagnostics (IVD) market, porters 5 force model
FIG 7. Global Infectious Diseases in-Vitro Diagnostics (IVD) market, pest analysis
FIG 8. Global Infectious Diseases in-Vitro Diagnostics (IVD) market, value chain analysis
FIG 9. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Infectious Diseases in-Vitro Diagnostics (IVD) market, regional snapshot 2017 & 2027
FIG 18. North America Infectious Diseases in-Vitro Diagnostics (IVD) market 2017 & 2027 (USD Billion)
FIG 19. Europe Infectious Diseases in-Vitro Diagnostics (IVD) market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific Infectious Diseases in-Vitro Diagnostics (IVD) market 2017 & 2027 (USD Billion)
FIG 21. Latin America Infectious Diseases in-Vitro Diagnostics (IVD) market 2017 & 2027 (USD Billion)
FIG 22. Global Infectious Diseases in-Vitro Diagnostics (IVD) market, company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の感染症用体外診断(IVD)市場2020-2027:製品別(機器、試薬、サービス)、技術別、用途別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆